A new study indicates that daily multivitamin intake may slow biological ageing markers, particularly in older adults. Further research is needed to confirm these findings.
Novo Nordisk's shares fell sharply after disappointing results from CagriSema's clinical trials, raising concerns about its future in the competitive weight-loss market.